Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?

Thomas R. Collins  |  Issue: January 2013  |  January 1, 2013

There is ongoing tension between discovery-driven research and the traditional hypothesis-driven research, when the goal should be to merge them, Dr. Brenner said.

A recent example of this merging can be seen in the lab of Vijray Kuchroo, DVM, PhD, professor of neurology at Harvard Medical School in Boston, where Dr. Kuchroo and collaborators have used new tools to analyze the role of genes in the differentiation of TH17 cells, which are important players in RA. That led to the discovery that serum and glucocorticoid-inducible kinase 1 (SGK-1) are closely linked to that process.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

SGK-1 is a regulator of sodium channels, and researchers later found that mice on a high-salt diet showed “measurably enhanced” TH17 cell differentiation.

“The new technologies and new tools that we have really aren’t in conflict with the old, hypothesis-driven approaches that some of us know and love,” Dr. Brenner said. “But they really work together with it and allow us to discover new things.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Thomas Collins is a freelance medical journalist based in Florida.

References

  1. Lundberg K, Bengtsson C, Kharlamova N, et al. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis. 2012 June 1. [Epub ahead of print]
  2. Malmström V, Amara K, Meffre E, et al. Generation and characterization of monoclonal anti-citrullinated antibodies from single RA synovial B cells. Ann Rheum Dis. 2012;71(suppl 3):315.
  3. Amara K, Steen J, Murray F, et al. Monoclonal IgG antibodies (ACPAs) from synovial fluid B cells of rheumatoid arthritis patients—antigen-driven affinity maturation and cross reactivity. Arthritis Rheum. 2012;64(suppl):S1091.
  4. Hughes-Austin JM, Deane KD, Derber LA, et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis. 2012 Aug 21. [Epub ahead of print]
  5. Wright GP, Notley CA, Xue SA, et al. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci USA. 2009;106:19078-19083.
  6. Van Herwijnen MJ, Wieten L, van der Zee R, et al. Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis. Proc Natl Acad Sci USA. 2012;109:14134-14139.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACPAACR/ARHP Annual MeetingRAResearchRheumatoid arthritis

Related Articles

    A Closer Look at Antibodies in RA: How Anti-Citrullinated Protein Antibodies, Anti-Modified Protein Autoantibodies & Rheumatoid Factor Activity Overlap

    December 17, 2020

    Recent evidence on how anti-citrullinated protein antibodies, anti-modified protein autoantibodies and rheumatoid factor activity overlap in RA demonstrate new ideas for diagnostics and pathophysiology.

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Antibodies Can Spot RA in the General Population

    May 9, 2016

    NEW YORK (Reuters Health)—Anti-citrullinated protein antibodies (ACPA), particularly high anti-CCP2 titers, can diagnose rheumatoid arthritis (RA) in the general population with a high degree of accuracy, a Swedish study suggests. ACPA are highly specific for RA, but until now the diagnostic accuracy of ACPA in the general population has not been “thoroughly assessed,” note Dr….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences